Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/56007
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBaralee Punyawudhoen_US
dc.contributor.authorNoppaket Singkhamen_US
dc.contributor.authorNarukjaporn Thammajaruken_US
dc.contributor.authorTheera Dalodomen_US
dc.contributor.authorStephen J. Kerren_US
dc.contributor.authorDavid M. Burgeren_US
dc.contributor.authorKiat Ruxrungthamen_US
dc.date.accessioned2018-09-05T03:07:40Z-
dc.date.available2018-09-05T03:07:40Z-
dc.date.issued2016-12-01en_US
dc.identifier.issn17512441en_US
dc.identifier.issn17512433en_US
dc.identifier.other2-s2.0-84996607034en_US
dc.identifier.other10.1080/17512433.2016.1235972en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84996607034&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/56007-
dc.description.abstract© 2016 Informa UK Limited, trading as Taylor & Francis Group. Introduction: Therapeutic drug monitoring (TDM) may be beneficial when applied to antiretroviral (ARV). Even though TDM can be a valuable strategy in HIV management, its role remains controversial. Areas covered: This review provides a comprehensive update on important issues relating to TDM of ARV drugs in HIV-infected patients. Articles from PubMed with keywords relevant to each topic section were reviewed. Search strategies limited to articles published in English. Expert commentary: There is evidence supporting the use of TDM in HIV treatment. However, some limitations need to be considered. The evidence supporting the use of routine TDM for all patients is limited, as it is not clear that this strategy offers any advantages over TDM for selected indications. Selected groups of patients including patients with physiological changes, patients with drug-drug interactions or toxicity, and the elderly could potentially benefit from TDM, as optimized dosing is challenging in these populations.en_US
dc.subjectMedicineen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleTherapeutic drug monitoring of antiretroviral drugs in HIV-infected patientsen_US
dc.typeJournalen_US
article.title.sourcetitleExpert Review of Clinical Pharmacologyen_US
article.volume9en_US
article.stream.affiliationsChiang Mai Universityen_US
article.stream.affiliationsThe HIV Netherlands Australia Thailand Research Collaborationen_US
article.stream.affiliationsUniversity of New South Wales (UNSW) Australiaen_US
article.stream.affiliationsAcademic Medical Centre, University of Amsterdamen_US
article.stream.affiliationsRadboud University Nijmegen Medical Centreen_US
article.stream.affiliationsChulalongkorn Universityen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.